Consensus statement for the treatment of infantile haemangiomas with propranolol

Sarah L. Smithson; Marius Rademaker; Susan Adams; Stuart Bade; Philip Bekhor; Samantha Davidson; Amanda Dore; Catherine Drummond; Gayle Fischer; Alexander Gin; Claire Grills; Anne Halbert; Zerina Lokmic; Emma McCahon; Vanessa A. Morgan; Dedee F. Murrell; David Orchard; Anthony Penington; Diana Purvis; John Relic; Susan Robertson; Aaron J. Robinson; Laura Scardamaglia; John Su; Swee Tan; Orli Wargon; Lachlan Warren; Li Chuen Wong; Tania Zappala; Roderic Phillips

doi:10.1111/ajd.12600

Consensus statement for the treatment of infantile haemangiomas with propranolol

Sarah L. Smithson, Marius Rademaker, Susan Adams, Stuart Bade, Philip Bekhor, Samantha Davidson, Amanda Dore, Catherine Drummond, Gayle Fischer, Alexander Gin, Claire Grills, Anne Halbert, Zerina Lokmic, Emma McCahon, Vanessa A. Morgan, Dedee F. Murrell, David Orchard, Anthony Penington, Diana Purvis, John RelicSusan Robertson, Aaron J. Robinson, Laura Scardamaglia, John Su, Swee Tan, Orli Wargon, Lachlan Warren, Li Chuen Wong, Tania Zappala, Roderic Phillips^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

54 Citations (Scopus)

Abstract

Although most infantile haemangiomas do not require treatment due to a natural history of spontaneous involution, some require early intervention. The Australasian Vascular Anomalies Network and the Australasian Paediatric Dermatology Network have developed a consensus statement for the treatment of infantile haemangiomas with oral propranolol. Infants with haemangiomas that are life threatening, at risk of ulceration, or at risk of causing a significant functional impairment, psychological impact or physical deformity should be treated early with oral propranolol. Oral propranolol is safe and effective and in most healthy infants oral propranolol can be started in an outpatient setting.

Original language	English
Pages (from-to)	155-159
Number of pages	5
Journal	Australasian Journal of Dermatology
Volume	58
Issue number	2
DOIs	https://doi.org/10.1111/ajd.12600
Publication status	Published - May 2017
Externally published	Yes

Access to Document

10.1111/ajd.12600

Cite this

Smithson, S. L., Rademaker, M., Adams, S., Bade, S., Bekhor, P., Davidson, S., Dore, A., Drummond, C., Fischer, G., Gin, A., Grills, C., Halbert, A., Lokmic, Z., McCahon, E., Morgan, V. A., Murrell, D. F., Orchard, D., Penington, A., Purvis, D., ... Phillips, R. (2017). Consensus statement for the treatment of infantile haemangiomas with propranolol. Australasian Journal of Dermatology, 58(2), 155-159. https://doi.org/10.1111/ajd.12600

@article{fbcb82cb2c3348f288491cfb15049e2d,

title = "Consensus statement for the treatment of infantile haemangiomas with propranolol",

abstract = "Although most infantile haemangiomas do not require treatment due to a natural history of spontaneous involution, some require early intervention. The Australasian Vascular Anomalies Network and the Australasian Paediatric Dermatology Network have developed a consensus statement for the treatment of infantile haemangiomas with oral propranolol. Infants with haemangiomas that are life threatening, at risk of ulceration, or at risk of causing a significant functional impairment, psychological impact or physical deformity should be treated early with oral propranolol. Oral propranolol is safe and effective and in most healthy infants oral propranolol can be started in an outpatient setting.",

keywords = "Australian, New Zealand, beta-blocker, consensus, hemangioma, infantile haemangioma, propranolol, vascular anomaly",

author = "Smithson, {Sarah L.} and Marius Rademaker and Susan Adams and Stuart Bade and Philip Bekhor and Samantha Davidson and Amanda Dore and Catherine Drummond and Gayle Fischer and Alexander Gin and Claire Grills and Anne Halbert and Zerina Lokmic and Emma McCahon and Morgan, {Vanessa A.} and Murrell, {Dedee F.} and David Orchard and Anthony Penington and Diana Purvis and John Relic and Susan Robertson and Robinson, {Aaron J.} and Laura Scardamaglia and John Su and Swee Tan and Orli Wargon and Lachlan Warren and Wong, {Li Chuen} and Tania Zappala and Roderic Phillips",

note = "Publisher Copyright: {\textcopyright} 2017 The Australasian College of Dermatologists",

year = "2017",

month = may,

doi = "10.1111/ajd.12600",

language = "English",

volume = "58",

pages = "155--159",

journal = "Australasian Journal of Dermatology",

issn = "0004-8380",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "2",

}

Smithson, SL, Rademaker, M, Adams, S, Bade, S, Bekhor, P, Davidson, S, Dore, A, Drummond, C, Fischer, G, Gin, A, Grills, C, Halbert, A, Lokmic, Z, McCahon, E, Morgan, VA, Murrell, DF, Orchard, D, Penington, A, Purvis, D, Relic, J, Robertson, S, Robinson, AJ, Scardamaglia, L, Su, J, Tan, S, Wargon, O, Warren, L, Wong, LC, Zappala, T & Phillips, R 2017, 'Consensus statement for the treatment of infantile haemangiomas with propranolol', Australasian Journal of Dermatology, vol. 58, no. 2, pp. 155-159. https://doi.org/10.1111/ajd.12600

TY - JOUR

T1 - Consensus statement for the treatment of infantile haemangiomas with propranolol

AU - Smithson, Sarah L.

AU - Rademaker, Marius

AU - Adams, Susan

AU - Bade, Stuart

AU - Bekhor, Philip

AU - Davidson, Samantha

AU - Dore, Amanda

AU - Drummond, Catherine

AU - Fischer, Gayle

AU - Gin, Alexander

AU - Grills, Claire

AU - Halbert, Anne

AU - Lokmic, Zerina

AU - McCahon, Emma

AU - Morgan, Vanessa A.

AU - Murrell, Dedee F.

AU - Orchard, David

AU - Penington, Anthony

AU - Purvis, Diana

AU - Relic, John

AU - Robertson, Susan

AU - Robinson, Aaron J.

AU - Scardamaglia, Laura

AU - Su, John

AU - Tan, Swee

AU - Wargon, Orli

AU - Warren, Lachlan

AU - Wong, Li Chuen

AU - Zappala, Tania

AU - Phillips, Roderic

PY - 2017/5

Y1 - 2017/5

N2 - Although most infantile haemangiomas do not require treatment due to a natural history of spontaneous involution, some require early intervention. The Australasian Vascular Anomalies Network and the Australasian Paediatric Dermatology Network have developed a consensus statement for the treatment of infantile haemangiomas with oral propranolol. Infants with haemangiomas that are life threatening, at risk of ulceration, or at risk of causing a significant functional impairment, psychological impact or physical deformity should be treated early with oral propranolol. Oral propranolol is safe and effective and in most healthy infants oral propranolol can be started in an outpatient setting.

AB - Although most infantile haemangiomas do not require treatment due to a natural history of spontaneous involution, some require early intervention. The Australasian Vascular Anomalies Network and the Australasian Paediatric Dermatology Network have developed a consensus statement for the treatment of infantile haemangiomas with oral propranolol. Infants with haemangiomas that are life threatening, at risk of ulceration, or at risk of causing a significant functional impairment, psychological impact or physical deformity should be treated early with oral propranolol. Oral propranolol is safe and effective and in most healthy infants oral propranolol can be started in an outpatient setting.

KW - Australian

KW - New Zealand

KW - beta-blocker

KW - consensus

KW - hemangioma

KW - infantile haemangioma

KW - propranolol

KW - vascular anomaly

UR - http://www.scopus.com/inward/record.url?scp=85014009698&partnerID=8YFLogxK

U2 - 10.1111/ajd.12600

DO - 10.1111/ajd.12600

M3 - Article

SN - 0004-8380

VL - 58

SP - 155

EP - 159

JO - Australasian Journal of Dermatology

JF - Australasian Journal of Dermatology

IS - 2

ER -

Consensus statement for the treatment of infantile haemangiomas with propranolol

Abstract

Access to Document

Other files and links

Fingerprint

Cite this